THEODORA AGBASI: Open Payments
NPI 1538593173 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$763 in 21 payments from 8 companies in 2025. Trend: 2023 $1,334 · 2024 $910 · 2025 $763
Food & beverage: $763
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 5 | $286 |
| Janssen Pharmaceuticals, Inc | 5 | $199 |
| Teva Pharmaceuticals USA, Inc. | 4 | $88 |
| Vanda Pharmaceuticals Inc. | 2 | $57 |
| E.R. Squibb & Sons, L.L.C. | 2 | $51 |
| Axsome Therapeutics, Inc. | 1 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
Products named: ARISTADA, INVEGA SUSTENNA, LYBALVI, FANAPT, INVEGA, COBENFY, AUSTEDO XR, UZEDY.
Industry payments across TX — which companies pay providers there.
